FDA Issues Final Rule on Safety and Effectiveness of Consumer Hand Sanitizers

The Food and Drug Administration (FDA) today issued a final rule designed to help ensure that hand sanitizers available over-the-counter (OTC) are safe and effective for those who rely on them. The rule establishes that certain active ingredients are not allowed to be used in OTC hand sanitizers, formally known as topical consumer antiseptic rub products, which are intended for use without water, that are marketed under the FDA’s OTC Drug Review. The final rule also seeks to ensure that the agency’s safety and effectiveness evaluations and determinations for consumer antiseptic rub active ingredients are consistent, up-to-date and appropriately reflect current scientific knowledge and increasing use patterns.

“Our action today aims to help provide consumers with confidence that the over-the-counter hand sanitizers they’re using are safe and effective when they don’t have access to water to wash with soap,” said Janet Woodcock, MD, director of the FDA’s Center for Drug Evaluation and Research. “In today’s final regulation we finalized the FDA’s previous determination that 28 active ingredients, including triclosan and benzethonium chloride, are not eligible for evaluation under the FDA’s OTC Drug Review for use in consumer antiseptic rubs. We’ve also reaffirmed our need for more data on three other active ingredients, including ethyl alcohol, which is the most commonly used ingredient in hand sanitizers, to help the agency ensure that these products are safe and effective for regular use by consumers. We believe industry has made good progress toward providing data and we will continue to provide updates to the public about the progress of collecting this data.”

Consumer antiseptic hand sanitizers provide a convenient alternative when hand washing with plain soap and water is unavailable. Millions of Americans use antiseptic rubs daily, sometimes multiple times a day, to help reduce bacteria on their hands. The Centers for Disease Control and Prevention advises that washing hands with plain soap and running water is one of the most important steps consumers can take to avoid getting sick and to prevent spreading infections to others. If soap and water are not available, the CDC recommends using an alcohol-based hand sanitizer that contains at least 60 percent alcohol.

As part of the June 30, 2016 proposed rule on consumer antiseptic rubs, the FDA requested additional scientific data to support the safety and effectiveness of active ingredients used in OTC consumer antiseptic rubs.

At this time, three active ingredients—benzalkonium chloride, ethyl alcohol, and isopropyl alcohol—are being deferred from further rulemaking to allow for the ongoing study and submission of additional safety and effectiveness data necessary to make a determination regarding whether these active ingredients are generally recognized as safe and effective for use in OTC consumer antiseptic rub products. Their status will be addressed either after completion and analysis of the studies or at another time, if these studies are not completed. At this time, the FDA does not intend to take action to remove hand sanitizers containing these three active ingredients from the market.

Less than 3 percent of the marketplace will be affected by the issuance of this final rule, as most OTC consumer antiseptic rubs use ethyl alcohol as the active ingredient.

The FDA is aware that retailers and pharmacies continue to market a very low number of consumer hand sanitizers containing benzethonium chloride, but that they stopped marketing hand sanitizers containing triclosan. Drug products containing any ineligible active ingredients will require approval under a new drug application or abbreviated new drug application prior to marketing.

This final rule completes a series of rulemaking actions in the FDA’s ongoing review of OTC antiseptic active ingredients to determine whether these ingredients are safe and effective for their intended uses. The FDA previously issued final rules on consumer antiseptic washes (Sept. 2016) and healthcare antiseptics (Dec. 2017)

“On behalf of our members who produce hand sanitizers and their ingredients, the American Cleaning Institute looks forward to providing additional data to ensure the FDA has complete and up-to-date information on ethanol and benzalkonium chloride used in these beneficial products,” says Richard Sedlak, executive vice president of technical and international affairs for ACI. “ACI welcomes the agency’s decision to allow adequate time to complete the new studies to generate the data the agency is requesting.”

Sedlak adds, “Consumers can continue to use hand sanitizer products with confidence as this regulatory process moves forward. We will work to ensure that these products remain available to help people stay clean and healthy in homes, day care centers, restaurants, and offices across the United States.”

Authors

    by
  • Kathy Lenox

    Kathy Lenox is the President of Microbe Solutions, LLC, a 100% women-owned company she established in 2017. With a diverse career, she managed offices for renowned establishments like Caesars Atlantic City and Trump Plaza Atlantic City. For over 25 years, she excelled as an Administrative Manager in the Warehouse Distribution industry, overseeing multimillion-dollar operations. Kathy's company, Microbe Solutions, specializes in manufacturing a highly effective, persistent hand sanitizer. She is committed to expanding its presence in both wholesale and retail markets. Her dedication extends to supplying the military with essential hygiene products. Kathy's vision for Microbe Solutions revolves around exceptional customer service and the continued exploration of innovative antimicrobial technology in new avenues.

  • Michael Hammer

    Michael Hammer is the Vice President of Operations at Microbe Solutions, a company specializing in antimicrobial products. With an extensive background in business and management, Michael co-founded Microbe Solutions with a commitment to promoting these products and achieving operational excellence. Having honed his expertise in various roles, from automotive management to medical billing and antimicrobial distribution, Michael brings a wealth of experience in product development and promotion. His vision for Microbe Solutions centers on expanding the reach of antimicrobial products in health and beauty sectors, all while prioritizing top-notch customer service. Over a relatively short period, he has achieved significant milestones, including securing EPA labels and establishing manufacturing processes. Michael's ultimate goal is to make Microbe Solutions' products accessible in major retail outlets, emphasizing their presence in big-box stores.